From the Meso Foundation Staff

Preliminary results released of Phase 1 clinical trial targeting mesothelin

Yesterday, at the annual meeting of the American Society of Gene and Cell Therapy in Chicago, researchers from Memorial Sloan Kettering Cancer Center released a preliminary report on their Phase 1 study into regionally delivered autologous mesothelin-targeted CAR T cells in patients with pleural mesothelioma.
Drs. Prasad Adusumilli, with co-authors Marjorie Zauderer, and Valerie Rusch (all […]

Read More